【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Pulmonary Arterial Hypertension Overview 8
Therapeutics Development 9
Pipeline Products for Pulmonary Arterial Hypertension – Overview 9
Pipeline Products for Pulmonary Arterial Hypertension – Comparative Analysis 10
Pulmonary Arterial Hypertension – Therapeutics under Development by Companies 11
Pulmonary Arterial Hypertension – Therapeutics under Investigation by Universities/Institutes 15
Pulmonary Arterial Hypertension – Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Pulmonary Arterial Hypertension – Products under Development by Companies 19
Pulmonary Arterial Hypertension – Products under Investigation by Universities/Institutes 23
Pulmonary Arterial Hypertension – Companies Involved in Therapeutics Development 24
Actelion Ltd 24
APT Therapeutics, Inc. 25
Arena Pharmaceuticals, Inc. 26
Asahi Kasei Pharma Corp. 27
Ascendis Pharma A/S 28
Bial – Portela & Ca, S.A. 29
Cardioxyl Pharmaceuticals, Inc. 30
Carolus Therapeutics, Inc. 31
Celladon Corporation 32
Celsion Corporation 33
Corridor Pharmaceuticals Inc. 34
Cytokinetics, Inc. 35
Eli Lilly and Company 36
Gilead Sciences, Inc. 37
HanAll Biopharma Co., Ltd. 38
Insmed Incorporated 39
Ironwood Pharmaceuticals, Inc. 40
Lacer, S.A. 41
Longevity Biotech, Inc 42
LTT Bio-Pharma Co., Ltd. 43
Mast Therapeutics, Inc. 44
Mezzion Pharma Co. Ltd. 45
miRagen Therapeutics, Inc. 46
Nippon Shinyaku Co., Ltd. 47
Novartis AG 48
PharmaIN Corporation 49
PhaseBio Pharmaceuticals, Inc. 50
Pluristem Therapeutics Inc. 51
Proteo, Inc. 52
Reata Pharmaceuticals, Inc. 53
Sagene Pharmaceuticals, Inc. 54
Silence Therapeutics plc 55
Sinoxa Pharma GmbH 56
Suda Ltd 57
Therametrics holding AG 58
Toray Industries, Inc. 59
United Therapeutics Corporation 60
Pulmonary Arterial Hypertension – Therapeutics Assessment 61
Assessment by Monotherapy Products 61
Assessment by Combination Products 62
Assessment by Target 63
Assessment by Mechanism of Action 66
Assessment by Route of Administration 69
Assessment by Molecule Type 71
Drug Profiles 73
(allopurinol + apocynin) – Drug Profile 73
(chlorthalidone + valsartan) – Drug Profile 74
ACP-009 – Drug Profile 75
Antibody for Cancer and PAH – Drug Profile 76
Antibody for Pulmonary Arterial Hypertension – Drug Profile 77
APT-102 – Drug Profile 78
bardoxolone methyl – Drug Profile 80
beraprost sodium nanoparticles SR – Drug Profile 83
beraprost sodium SR – Drug Profile 84
BIA-51058 – Drug Profile 86
bosentan CR – Drug Profile 87
CT-2009 – Drug Profile 88
DasKloster-1000-01 – Drug Profile 89
Elafin – Drug Profile 91
esuberaprost sodium – Drug Profile 94
fasudil – Drug Profile 95
GS-4997 – Drug Profile 96
imatinib mesylate – Drug Profile 97
IW-1973 – Drug Profile 99
LA-419 – Drug Profile 100
lisuride – Drug Profile 101
macitentan – Drug Profile 103
Mydicar – Drug Profile 106
Oligonucleotide to Inhibit Endothelin-1 for Pulmonary Arterial Hypertension – Drug Profile 108
Oligonucleotide to Inhibit MicroRNA-145 for Pulmonary Arterial Hypertension – Drug Profile 109
PB-1046 – Drug Profile 110
PB-1120 – Drug Profile 112
Peptide to Antagonize Urotensin-II Receptor for PAH – Drug Profile 113
PGC-VIP – Drug Profile 114
PK-10453 – Drug Profile 115
R-190 – Drug Profile 116
ralinepag – Drug Profile 118
RNAi Oligonucleotide to Inhibit miR-145 for PAH – Drug Profile 120
selegiline + PDE-5 Inhibitor – Drug Profile 121
selexipag – Drug Profile 122
Small Molecule for Pulmonary Arterial Hypertension – Drug Profile 124
Small Molecule to Antagonize Notch Receptor for Pulmonary Arterial Hypertension and Hypoxia – Drug Profile 125
Small Molecule to Inhibit Arginase for Vascular Dysfunction, PAH and Erectile Dysfunction – Drug Profile 126
Small Molecule to Inhibit Myosin for COPD, Asthma And Pulmonary Arterial Hypertension – Drug Profile 127
Small Molecule to Inhibit Soluble Epoxide Hydrolase for Pulmonary Arterial Hypertension – Drug Profile 128
Small Molecules to Activate ACE2 for Pulmonary Arterial Hypertension – Drug Profile 129
Small Molecules to Antagonize 5-HT1B for Pulmonary Arterial Hypertension – Drug Profile 130
sodium nitrite – Drug Profile 131
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 133
SUD-004 – Drug Profile 135
Synthetic Peptide to Agonize VPAC2 for Pulmonary Arterial Hypertension – Drug Profile 136
tadalafil – Drug Profile 137
TPN-171 – Drug Profile 139
treprostinil diolamine – Drug Profile 140
TXA-127 – Drug Profile 141
udenafil – Drug Profile 143
Pulmonary Arterial Hypertension – Recent Pipeline Updates 145
Pulmonary Arterial Hypertension – Dormant Projects 168
Pulmonary Arterial Hypertension – Discontinued Products 169
Pulmonary Arterial Hypertension – Product Development Milestones 170
Featured News & Press Releases 170
Appendix 176
Methodology 176
Coverage 176
Secondary Research 176
Primary Research 176
Expert Panel Validation 176
Contact Us 176
Disclaimer 177
【レポート販売概要】
■ タイトル:肺動脈性肺高血圧症(Pulmonary Arterial Hypertension):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Pulmonary Arterial Hypertension - Pipeline Review, H1 2015
■ 発行日:2015年3月19日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6252IDB
■ 調査対象地域:グローバル
- Liver Cirrhosis:グローバル臨床試験レビューH1, 2013Liver Cirrhosis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H1, 2013" provides data on the Liver Cirrhosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cirrhosis. It includes an overview of the trial numbers and their recruitment status as …
- 世界の受動光ネットワーク(PON)装置市場動向(2012-2016)TechNavio's analysts forecast the Global Passive Optical Network (PON) Equipment market to grow at a CAGR of 23.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing growth of PON equipment in China. The Global PON Equipment market has also been witnessing the development of ultra-high capacity optical networks. However, the declining ave …
- エネルギー管理システム(EMS)の世界市場:デマンドレスポンス(DR)、IEMS、BEMS、HEMSAbout Energy Management System An energy management system (EMS) uses computer-aided tools to monitor, control, and optimize electrical loads. The EMS allows consumers to monitor and reduce the energy consumption of electrical and electronic devices and conserve energy. In this system, energy consumption can be easily monitored through cell phones, tablets, or other communication devices. It also …
- ケミカルピーリングの世界市場About Chemical Peel Superficial or light peels are the mildest type of peels available. They only remove the top layer of the skin, known as the epidermis, and give skin an instant brighter look as well as a smoother, and more even texture. They are being demanded by the people who need to minimize the fine lines and wrinkles, mild acne scarring, sun damage, age spots, and dry or flaking skin. The …
- 赤外線センサの世界市場:熱電対型、焦電素子型、ボロメータ型、InGaAs、MCT赤外線センサAbout infrared (IR) sensors An infrared (IR) sensor emits and detects IR radiation to measure heat and detect motion. These IR sensors can be broadly classified as passive IR (PIR) sensors and active IR (AIR) sensors. PIR sensors only measure IR radiation, while AIR sensors measure and emit IR radiations. IR sensors are integrated with different devices used in surveillance, automobiles, testing, …
- 世界の小型自動車用OE基礎ブレーキ装置市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE foundation braking sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE foundation braking market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategi …
- 特殊殺生物剤の世界市場:抗菌剤、殺虫剤About Specialty Biocides Specialty biocides are microorganisms or chemical substances that are used to control and prevent the damage to manufactured or natural products. Specialty biocides are categorized into: • Antimicrobials: Includes antibiotics, germicides, antivirals, antibacterials, antiprotozoals, antifungals, and antiparasitics • Pesticides: Includes herbicides, fungicides, insecticides, …
- クラウド・プロフェッショナル・サービスの世界市場:コンサルティング、システム及びネットワーク統合、導入及びサポートThe cloud based services are progressively being adopted by businesses across a broad spectrum of verticals mentioned in the report such as banking and financial services, insurance, public sector and utilities, transportation, healthcare, telecommunication and IT, education, retail, manufacturing and other verticals too. The complete cloud professional services market analysis consists of evaluat …
- SPECT(単一光子放射断層撮影)の世界市場2017-2021About SPECTSPECT or single-photon emission computed tomography is a nuclear medicine tomographic imaging technique that involves the generation of images using gamma radiation. This technique is used for diagnosing, monitoring, and treating various diseases related to oncology, neurology, cardiology, and other infectious diseases. Technavio’s analysts forecast the global SPECT market to grow at a …
- 石油コークスの世界市場:製品別(燃料グレードコークス、か焼コークス)、用途別(アルミニウム・その他の金属、セメント、貯蔵、鉄鋼、電力、その他)、地域別予測Global Petroleum coke Market to reach USD 36227.2 million by 2025. Global Petroleum coke Market valued approximately USD 16680 million in 2016 is anticipated to grow with a healthy growth rate of more than 9% over the forecast period 2017-2025. Key factors which gives growth to the Petroleum coke market are directly linked to the petroleum refining, cement and power industry. Growing power and cem …
- 世界の赤外線画像市場動向(2012-2016)TechNavio's analysts forecast the Global Infrared Imaging market to grow at a CAGR of 12.2 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for increased energy savings. The Global Infrared Imaging market has also been witnessing the development of high-speed infrared cameras. However, the need for increased investment could pose a challenge …
- Petsec Energy Limited:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Petsec Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Petsec Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 2014年戦略提言:アメリカの血液及びフローサイトメトリー市場Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400.SummaryThis comprehensive report contains 275 pages, 36 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry markets during the next five years. The report explores business and tech …
- スタジアム照明の世界市場:光源別(LED、HPS、HID、インダクションライト、その他)、提供別(ランプ・照明器具、サービス、制御システム)、ソリューションのセットアップ別(屋外、屋内)、設置別(レトロフィット、新規設置)、地域別予測Global Stadium Lighting Market to reach USD 717.2 million by 2025. Global Stadium Lighting Market valued approximately USD 369.1 million in 2016 is forecasted to grow with a healthy growth rate of more than 7.66% over the forecast period 2018-2025. The major factors speculated to augment the markets are upcoming national & international sports events, lessening costs of LEDs & life-cycle operating …
- モバイルUC&C(ユニファイドコミュニケーション/コラボレーション)の世界市場:UC&Cソフトウェア、UC&CサービスAbout Mobile UC&C UC&C is a system that integrates the real-time communication services, such as telephony instant messaging, videoconferencing, data sharing, and others, with non-real-time communication services, such as unified messaging (e-mail, SMS, and fax). It enables an individual to send a message on one medium and receive the same message on another medium. Mobile UC&C utilizes BYOD devic …